UNSPSC 51284145: Ceftibuten dihydrate

This classification denotes a cephalosporin antibiotic C15H14N4O6S2.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 62F4443RWP, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl)amino)-8-oxo-, dihydrate, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as ceftibuten dihydrate, which bears US NIH Compound Identifier 5282241.

UNSPSC 51284145 Ceftibuten dihydrate is a Commodity code that in practice encompasses a far broader range of pharmaceutical products and medical supplies than its nominal title suggests. Recent state and local solicitations tagged to this code show procurement of naloxone and drug deactivation systems, comprehensive medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products distributed through cooperative purchasing vehicles, and direct-to-manufacturer prescription programs. The issuing bodies span state health and human services commissions, county health departments, municipal fire departments, and multi-state cooperative purchasing alliances. Work under the code involves product sourcing, vendor qualification against FDA and manufacturing-practice standards, compliance with supply chain security regulations, and logistics coordination including quarterly or on-demand delivery schedules.

Recent activity concentrates in Florida, Texas, Minnesota, and Oregon. Seminole County, Florida released an IFB (Solicitation IFB60459723LAS, due July 26, 2026) for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to its Community Health Building. The City of Tampa issued an IFB (26P00145, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, with a 5% bid discount reserved for certified Small Local Business Enterprises. The Texas Health and Human Services Commission posted a Request for Information (HHS0017013, due April 3, 2026) soliciting vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The Minnesota Department of Administration's Office of State Procurement, administering the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, requiring vendors to work through AmerisourceBergen, Cardinal Health, or Morris & Dickson wholesalers.